Table 3.

Predictors of Medium-Term Nonremission With Average Follow-Up Duration of 11 Months

Variables	HR	95% CI	Standard Error	P Value
Demographics
Age	1.0	1.0, 1.0	0.01	0.879
BMI	1.0	1.0, 1.1	0.02	0.248
Sex	1.2	0.5, 2.9	0.53	0.703
Path-confirmed	0.6	0.2, 1.6	0.29	0.280
White	0.9	0.4, 2.1	0.39	0.793
Black	1.2	0.4, 3.5	0.65	0.755
Asian	0.9	0.2, 4.0	0.68	0.855
Nadir	1.1	1.1, 1.2	0.03	<0.001
Nadir POD	1.1	1.0, 1.3	0.09	0.087
Cortisol
Post-CRH % change cortisol	1.0	1.0, 1.0	0.00	0.112
Post-CRH avg cortisol	1.0	0.9, 1.0	0.02	0.252
Post-CRH max cortisol	1.0	0.9, 1.0	0.02	0.141
POD-0 at noon cortisol	1.0	1.0, 1.1	0.01	0.070
POD-0 at 6 pm cortisol	1.0	1.0, 1.1	0.01	0.021
POD-0 avg cortisol	1.0	1.0, 1.1	0.02	0.008
POD-1 at midnight cortisol	1.0	1.0, 1.1	0.02	0.046
POD-1 at 6 am cortisol	1.1	1.0, 1.1	0.02	<0.001
NEPV cortisol	1.1	1.0, 1.1	0.03	0.023
ACTH
Post-CRH % change ACTH	1.0	1.0, 1.0	0.00	0.222
Post-CRH avg ACTH	1.0	1.0, 1.0	0.00	0.188
Post-CRH max ACTH	1.0	1.0, 1.0	0.00	0.128
POD-0 at noon ACTH	1.0	1.0, 1.0	0.00	0.077
POD-0 at 6 pm ACTH	1.0	1.0, 1.0	0.00	0.116
POD-0 avg ACTH	1.0	1.0, 1.0	0.00	0.026
POD-1 at midnight ACTH	1.0	1.0, 1.1	0.01	0.002
POD-1 at 6 am ACTH	1.1	1.0, 1.1	0.01	<0.001
NEPV ACTH	1.0	1.0, 1.0	0.00	0.025

Results from Cox regression with nonremission as the dependent variable.